← Back to Search

Survivorship Care for Ovarian Cancer (POSTCARE-O Trial)

N/A

Recruiting

Led By Elizabeth Kvale, MD,MPH

Research Sponsored by Baylor College of Medicine

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Within 6 months of completion of initial treatment (continued maintenance therapy okay)

Stage 2-4 ovarian cancer

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 and 24 weeks

Awards & highlights

POSTCARE-O Trial Summary

This trial tests a new intervention to support women living with ovarian cancer after initial treatment. It evaluates if it improves quality of life compared to usual care.

Who is the study for?

This trial is for women who have completed initial treatment for stage 2-4 ovarian cancer within the last 6 months. They must have undergone surgery, chemotherapy, biologics, or maintenance therapy and be able to consent in English or Spanish. Women admitted to hospice after ovary cancer treatment cannot participate.Check my eligibility

What is being tested?

The study tests a support process called POSTCare Survivorship transition designed for women post-ovarian cancer treatment. It aims to improve their quality of life during survivorship. Participants will either receive this specialized care or usual care and will be compared over a period of 12 weeks.See study design

What are the potential side effects?

Since the intervention involves supportive care rather than medication, typical drug side effects are not expected. However, participants may experience emotional or psychological responses as they engage with the survivorship transition process.

POSTCARE-O Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I finished my initial cancer treatment less than 6 months ago.

Select...

My ovarian cancer is at stage 2, 3, or 4.

POSTCARE-O Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 and 24 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 and 24 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 and 24 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Secondary outcome measures

Depressive Symptom Burden

Quality of Life by FACT-O

Recurrence Fear

+1 more

POSTCARE-O Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Intervention groupExperimental Treatment1 Intervention

Group received care Using POSTCare process

Group II: Usual CareActive Control1 Intervention

Group received usual care

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of Texas Southwestern Medical CenterOTHER

1,048 Previous Clinical Trials

1,053,615 Total Patients Enrolled

4 Trials studying Ovarian Neoplasms

15 Patients Enrolled for Ovarian Neoplasms

Cancer Prevention Research Institute of TexasOTHER

50 Previous Clinical Trials

98,318 Total Patients Enrolled

The University of Texas Health Science Center, HoustonOTHER

904 Previous Clinical Trials

320,840 Total Patients Enrolled

1 Trials studying Ovarian Neoplasms

24 Patients Enrolled for Ovarian Neoplasms

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment still available for this experimental protocol?

"Clinicaltrials.gov's data states that this investigation is no longer seeking participants, as the trial was initially posted on October 1st 2023 and last updated 13th September of the same year. Despite its inactivity, there are 1918 other clinical trials searching for test subjects currently."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Survivorship Care for Women Living With Ovarian Cancer: (POSTCARE-O)

Elizabeth A Kvale 2023. "Survivorship Care for Women Living With Ovarian Cancer: (POSTCARE-O)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05752448.

All > Depression Dallas